glp-1 osteoporosis AAOS | A new study presented at #AAOS2026 revealed use may be linked to a 29% higher risk of after five years. As use of GLP-1 Weight Loss Drugs May

Drugs R D

What distinguishes B12 injections from IV therapy

BPC-157 is widely studied for its association with tissue maintenance, angiogenesis, cellular recovery pathways, and healing-related biological mechanisms

Here are a few with mixed results

Our Hillsboro location has also been awarded the PCPCH Health Equity Designation

Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity